Your Heart Racing for No Reason? Your Genes May Be Causing It.

NOS3 produces nitric oxide, a signaling molecule that tells your blood vessels to relax and dilate. When you stand up, this reflex dilation is what prevents blood from pooling in your legs and ensures adequate blood flow to your brain. It’s a core part of blood pressure regulation and cardiovascular responsiveness to position changes.

The Glu298Asp variant of NOS3 is carried by roughly 30-40% of the population. This variant reduces the amount of nitric oxide your endothelium can produce, impairing your blood vessels’ ability to dilate on demand. Your blood vessels are stiffer and less responsive. The reflex dilation that should happen automatically when you stand is sluggish or incomplete.

For you, this means your blood vessels don’t relax quickly enough when position changes demand it. Blood pools more easily in your lower body when standing. Your heart compensates by racing to pump harder and faster, trying to force blood upward against vessels that won’t dilate. You feel dizzy, your vision darkens, your heart pounds. Your blood pressure may actually drop because your vessels can’t maintain enough pressure in your legs and torso.

ACE is the enzyme that converts angiotensin I into angiotensin II, a powerful vasoconstrictor that raises blood pressure and promotes sodium retention. Your body uses this system to maintain blood pressure during position changes and stress. Too little ACE activity, and blood pressure drops too easily. Too much, and blood vessels constrict excessively, blood pressure stays elevated, and your heart works harder than it should.

The ACE I/D polymorphism determines how much ACE enzyme you produce. The D/D homozygous genotype is carried by roughly 25% of the population. People with D/D genotype have significantly higher ACE activity, producing more angiotensin II and maintaining higher baseline blood pressure and blood vessel constriction. Your cardiovascular system is biased toward vasoconstriction and higher pressure.

This means your blood vessels are tighter than the population average. When you stand, instead of a balanced relaxation and constriction response, your vessels constrict more aggressively. Your heart rate spikes to compensate. You feel a clamping sensation in your chest. Your blood pressure response to position changes is exaggerated. Over time, this excess vascular constriction drives fatigue and contributes to the oscillating heart rate pattern of POTS.

MTHFR is the enzyme that converts dietary folate into methylfolate, the form your cells can actually use. Methylfolate is essential for producing neurotransmitters, synthesizing DNA, regulating homocysteine, and crucially, producing ATP, the energy currency in your mitochondria. Your heart and blood vessel cells are energy-intensive. They need reliable ATP production to function smoothly.

The MTHFR C677T variant is carried by roughly 40% of European ancestry populations. This variant reduces MTHFR enzyme efficiency by 40-70%, meaning your cells cannot convert dietary folate efficiently into usable methylfolate, leaving you functionally depleted at the cellular level. You may eat a folate-rich diet and still have impaired methylation and reduced ATP production.

For your cardiovascular system, this means your heart and blood vessel cells are running on reduced energy. ATP production is sluggish. Your heart cannot generate consistent, stable rhythm. Your blood vessel cells cannot maintain proper membrane potential or respond quickly to regulatory signals. You feel fatigue disproportionate to your activity level. Your heart dysrhythmias worsen when you’re already tired or metabolically stressed. Your symptoms are worse in the morning when cellular energy is lowest.

COMT breaks down dopamine, norepinephrine, and epinephrine, the stress hormones your body releases during the fight-or-flight response. When you face stress or a physical challenge like standing up, your sympathetic nervous system releases these catecholamines to increase heart rate and blood pressure. Once the stressor passes, COMT should clear them out quickly so your nervous system can settle. If COMT is slow, these stress hormones linger in your bloodstream and brain.

The COMT Val158Met variant is carried by roughly 25% of people as homozygous slow. Slow COMT means your body takes longer to metabolize dopamine, norepinephrine, and epinephrine, keeping stress hormones elevated even after the stressor has passed. Your nervous system stays in a partial fight-or-flight state chronically.

With POTS, this is devastating. You stand up, your body releases catecholamines to support blood pressure. But your slow COMT can’t clear them efficiently. Stress hormones keep climbing. Your heart rate accelerates beyond what’s needed. You feel wired, anxious, jittery. Your blood pressure spikes higher than it should. You overshoot the mark and can’t settle back down quickly. This is why your symptoms feel like panic mixed with dysrhythmia. Your neurotransmitter system is stuck in overdrive.

SCN5A encodes the Nav1.5 sodium channel, the primary ion channel that initiates electrical impulses in your heart muscle. When this channel opens correctly, sodium rushes in, depolarizing the cell and triggering the heartbeat. When it closes properly, repolarization happens and the heart relaxes. This opening and closing needs to happen in perfect timing, thousands of times per day, for your heart rhythm to stay stable.

Variants in SCN5A are less common than variants in the other genes here, but when present, they significantly disrupt cardiac electrical function. SCN5A variants can slow sodium channel kinetics, prolong the electrical refractory period, or cause early repolarization, all of which destabilize the precise electrical timing your heart needs. Your heart’s pacemaking becomes irregular.

You experience this as an irregular heartbeat, skipped beats, or runs of tachycardia that feel unpredictable. Unlike a blocked artery or a structural defect, your heart’s electrical system is simply receiving slightly altered instructions. Your EKG might show subtle variations or it might look normal at rest, but during position changes or stress, the instability becomes obvious. You feel your heart stuttering, fluttering, or racing erratically. Stimulants worsen it dramatically.

KCNQ1 encodes a potassium channel that plays a critical role in repolarizing your heart cells after they fire. When the action potential has passed and sodium channels close, potassium channels like KCNQ1 open to let potassium flow out, returning the cell to resting potential. This repolarization phase is just as important as depolarization. If it’s too slow or too fast, your heart’s electrical rhythm destabilizes.

Variants in KCNQ1 are relatively uncommon in the general population but when present, they impair repolarization kinetics. KCNQ1 variants can prolong the QT interval, meaning repolarization takes too long, creating windows of electrical instability where dangerous arrhythmias can initiate. Your heart’s recovery phase is sluggish.

You feel this as palpitations, especially after meals, with exercise, or during stress. Your heart rate may surge and then take too long to settle back down. You might notice your symptoms are worse when your potassium or magnesium is low, or when you’re dehydrated. Unlike the other genes here, KCNQ1 variants carry real risk for serious arrhythmias under certain conditions. This is one where genetic knowledge is genuinely protective because you can avoid the triggers that provoke the instability.